Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells

Human Gene Therapy

Volumn 14, Issue 11, 2003, Pages 1089-1105

  Zhou, Xianzheng ^a,b   Cui, Yan ^a,c   Huang, Xin ^a,b   Yu, Zhiwei ^a   Thomas, Amy M ^a   Ye, Zhaohui ^a   Pardoll, Drew M ^a   Jaffee, Elizabeth M ^a   Cheng, Linzhao ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c LOUISIANA STATE UNIV HLTH SCI C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; TUMOR ANTIGEN; VIRUS PROTEIN; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN SPECIFICITY; ARTICLE; CANCER; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; EF1ALPHA GENE; GENE CONTROL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LEUKEMIA CELL LINE; LYMPHOCYTE; MEMORY CELL; MURINE STEM CELL VIRUS; ONCOVIRINAE; PGK GENE; PHENOTYPE; PROMOTER REGION; REPORTER GENE; RETROVIRUS; T LYMPHOCYTE ACTIVATION; TRANSGENE; VIRUS GENE;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; CELL LINE; DEFECTIVE VIRUSES; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; KIDNEY NEOPLASMS; KINETICS; LENTIVIRUS; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; MICE; RETROVIRIDAE; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; MURINE STEM CELL RETROVIRAL VECTOR; ONCOVIRINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0037812246     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322124800     Document Type: Article

References (72)

1. AMADO, R.G., and CHEN, I.S. (1999). Lentiviral vectors: The promise of gene therapy within reach? Science 285, 674-676.
2. AUTEN, J., AGARWAL, M., CHEN, J., SUTTON, R., and PLAVEC, I. (1999). Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages. Hum. Gene Ther. 10, 1389-1399.
3. AYUK, F.A., LI, Z., KÜHLCKE, K., LINDEMANN, C., SCHADE, U.M., ECKERT, H.-G., ZANDER, A.R., and FEHSE, B. (1999). Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements. Gene Ther. 6, 1788-1792.
4. BLAESE, R.M, CULVER, K.W., MILLER, A.D., CARTER, C.S., FLEISCHER, T., CLERICI, M., SHEARER, G., CHANG, L., CHIANG, Y., TOLSTOSHEV, P., GREENBLATT, J.J., ROSENBERG, S.A., KLEIN, H., BERGER, M., MULLEN, C.A., EAMSEY, W.J., MUUL, L., MORGAN, R.A., and ANDERSON, F.A. (1995). T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480.
5. BORDIGNON, C., NOTARANGELO, L.D., NOBILI, N., FERRARI, G., CASORATI, G., PANINA, P., UGAZIO, A.G., and MAVILIO, F. (1995). Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475.
6. BUKRINSKY, M.I., SHAROVA, N., DEMPSEY, M.P., STANWICK, T.L., BUKRINSKAYA, A.G., HAGGERTY, S., and STEVENSON. M. (1992). Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U.S.A. 89, 6580-6584.
7. BUKRINSKY, M.I., HAGGERTY, S., DEMPESEY, M.P., SHAROVA, N., ADZHUBEL, A., SPITZ, L. LEWIS, P., GOLDFARB, D., EMERMAN, M., and STEVENSON, M. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669.
8. BUNNELL, B.A., MUUL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
9. - human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. U.S.A. 96, 2988-2993.
10. CHENG, L., DU, C., MURRAY, D., TONG, T., ZHANG, Y.A., CHEN, B.P., and HAWLEY, R.G. (1997). A GFP reporter system to assess gene transfer and expression in viable human hematopoietic progenitor cells. Gene Ther. 4, 1013-1022.
11. CHINNASAMY D., CHINNASAMY N., ENRIQUEZ M.J., OTSU, M., MORGAN, R.A., and CANDOTTI, F. (2000). Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood 96, 1309-1316.
12. COSTELLO, E., MUNOZ, M., BUETTL E., MEYLAN, P.R.A., DIGGELMANN, H., and THALI, M. (2000). Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther. 7, 596-604.
13. CUI, Y., GOLOB, J., KELLEHER, E., PARDOLL, D., and CHENG, L. (2002). Targeting transgene expression to antigen presenting cells derived from lentivirus transduced human hematopoietic stem/progenitor cells. Blood 15, 399-408.
14. L restores cell survival, but not proliferation and effector differentiation in CD28-deficient T lymphocytes. J. Exp. Med. 191, 2031-2037.
15. DARDALHON, V., NORAZ, N., POLLOK, K., REBOUISSOU, C., BOYER, M., BAKKER, A.Q., SPITS, H., and TAYLOR, N. (1999). Green fluorescence protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. Hum. Gene Ther. 10, 5-14.
16. DARDALHON, V., JALECO, S., REBOUISSOU, C., FERRAND, C., SKANDER, N., SWAINSON, L., TIBERGHIEN, P., SPITS, H., NORAZ, N., and TAYLOR, N. (2000). Highly efficient gene transfer in naïve human T cells with a murine leukemia virus-based vector. Blood 96, 885-893.
17. DARDALHON, V., HERPERS, B., NORAZ, N., PFLUMIO, F., GUETARD, D., LEVEAU, C., DUBART-KUPPERSCHMITT, A., CHARNEAU, P., and TAYLOR, N. (2001). Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 8, 190-198.
18. DIETRICH, P.Y., WALKER, P.R., SCHNURIGER, V., SAAS, P., PERRIN, G., GUILLARD, M., GAUDIN, C., and CAIGNARD, A. (1997). TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture. Int. Immunol. 9, 1073-1083.
19. + cells. Blood 95, 445-452.
20. DUCREY-RUNDQUIST, O., GUYADER, M., and TRONO, D. (2002). Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J. Virol. 76, 9103-9111.
21. DUDLEY, M.E., WUNDERLICH, J.R., ROBBINS, P.F., YANG, J.C., HWU, P., SCHWARTZENTRUBER, D.J., TOPALIAN, S.L., SHERRY, R., RESTIFO, N.P., HUBICKI, A.M., ROBINSON, M.R., RAFFELD, M., DURAY, P., SEIPP, C.A., ROGERS-FREEZER, L., MORTON, K.E., MAVROUKAKIS, S.A., WHITE, D.E., and ROSENBERG, S.A. (2002). Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850-854.
22. DULL, T., ZUFFEREY, R., KELLY, M., MANDEL, R.J., NGUYEN, M., TRONO, D., and NALDINI, L. (1998). A third-generation lentiviral vector with a conditional packaging system. J. Virol. 72, 8463-8471.
23. FISCHER, A., HACEIN-BEY, S., and Cavazzana-Calvo, M. (2002). Gene therapy of severe combined immunodeficiencies. Nat. Rev. Immunol. 2, 615-621.
24. FOLLENZI, A., AILLES, L.E., BAKOVIC, S., GEUNA, M., and NALDINI, L. (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217-222.
25. GALLARDO, H.F., TAN, C., ORY, D., and SADELAIN, M. (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952-957.
26. GAO, Z., GOLOB, J., TANAVDE, V.M, CIVIN, C.I., HAWLEY, R.G., and CHENG, L. (2001). High levels of transgene expression following long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells 19, 247-259.
27. GREENBERG, P.D., and RIDDELL, S.R. (1999). Deficient cellular immunity-finding and fixing the defects. Science 285, 546-551.
28. + cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2, 71-80.
29. HARADA, M., LI, Y.F., EL-GAMIL M., OHNMACHT G.A., ROSENBERG, S.A., and ROBBINS, P.F. (2001). Melanoma-reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types. J. Immunother. 24, 323-333.
30. HWU, P., SHAFER, G.E., TREISMAN, J., SCHINDLER, D.G., GROSS, G., COWHERD, R., ROSENBERG, S.A., and ESHHAR, Z. (1993). Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor γ chain. J. Exp. Med. 178, 361-366.
31. KAFRI, T., BLOMER, U., PETERSON, D.A., GAGE, F.H., and VERMA, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
32. KESSELS, H.W.H.G., VAN DEN BOOM, M.D., SPITS, H., HOOIJBERG, E., and SCHUMACHER, T.N.M. (2000). Changing T cell specificity by retroviral T cell receptor display. Proc. Natl. Acad. Sci. U.S.A. 97, 14578-14583.
33. KOHN, D.B., WEINBERG, K.I., NOLTA, J.A., HEISS, L.N., LENARSKY, C., CROOKS, G.M., HANLEY, M. E., ANNETT, G., BROOKS, J.S., EL-KHOUREIY, A., LAWRENCE, K., WELLS, S., MOEN, R.C., BASTIAN, J., WILLIAMS-HERMAN, D.E., ELDER, M., WARA, D., BOWEN, T., HERSHFIELD, M.S., MULLEN, C.A., BLAESE, R.M., and PARKMAN, R. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1, 1017-1023.
34. + cells in ADA-deficient SCID neonates. Nat. Med. 4, 775-780.
35. LAM, J.S., REEVES, M.E., COWHERD, R., ROSENBERG, S.A., and HWU, P. (1996). Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum. Gene Ther. 7, 1415-1422.
36. LIU, M.-L., WINTHER, B.L., and KAY, M.A. (1996). Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70, 2497-2502.
37. MAHER, J., BRENTJENS, R.J., GUNSET, G., RIVIERE, I., and SADELAIN, M. (2002). Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ/CD28 receptor. Nat. Biotechnol. 20, 70-75.
38. MASCARENHAS, L., STRIPECKE, R., CASE, S.S., XU, D., WEINBERG, K.I., and KOHN, D.B. (1998). Gene delivery to human B-precursor acute lymphoblastic leukemia cells. Blood. 92, 3537-3545.
39. MAURICE, M., VERHOEYEN, E., SALMON, P., TRONO, D., RUSSELL, S.J, and COSSET, F.L. (2002). Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. Blood 99, 2342-2350.
40. MAVILIO, F., FERRARI, G., ROSSINI, S., NOBILI, N., BONINI, C., CASORATI, G., TRAVERSARI, C., and BORDIGNON, C. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997.
41. MIYOSHI, H., TAKAHASHI, M., GAGE, F.H., and VERMA, I.M. (1997). Stable and efficient gene transfer into the retina using a HIV-1-based lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 94, 10319-10323.
42. MIYOSHI, H., BLÖMER, U., TAKAHASHI, M., GAGE, F.H., and VERMA, I.M. (1998). Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150-8157.
43. MIYOSHI, H., SMITH, K.A., MOSIER, D., VERMA, I.M., and TORBETT, B.E. (1999). Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682-686.
44. NALDINI, L., BLÖMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D, (1996a). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
45. NALDINI, L., BLÖMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996b). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
46. NALDINI, L. (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9, 457-463.
47. PARKMAN, R., WEINBERG, K., CROOKS, G., NOLTA, J., KAPOOR, N., and KOHN, D. (2000). Gene therapy for adenosine deaminase deficiency. Annu. Rev. Med. 51, 33-47.
48. PIERSON, T., MCARTHUR, J., and SILICIANO, R.F. (2000). Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18, 665-708.
49. PLAVEC, I., AGARWAL, M., HO, K.E., PINEDA, M., AUTEN, J., BAKER, J., MATSUZAKI, H., ESCAICH, S., BONYHADI, M., and BOHNLEIN, E. (1997). High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: Implication for gene therapy of AIDS. Gene Ther. 4, 128-139.
50. POZNANSKY, M., LEVER, A., BERGERON, L., HASELTINE, W., and SODROSKI, J. (1991). Gene transfer into human lymphocytes by a defective human immunideficiency virus type 1 vector. J. Virol. 65, 532-536.
51. RAMEZANI, A., HAWLEY, T.S., and HAWLEY, R.G. (2000). Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol. Ther. 2, 458-469.
52. REISER, J., HARMISON, G., KLUEPFEL-STAHL, S., BRADY, R.O., KARLSSON, S., and SCHUBERT, M. (1996). Transduction of non-dividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. U.S.A. 93, 15266-15277.
53. RIDDELL, S.R., and GREENBERG, P.D. (1995). Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13, 545-586.
54. RIVIERE, I., GALLARDO, H.F., HAGANI, A.B., and SADELAIN, M. (2000). Retroviral-mediated gene transfer in primary murine and human T-lymphocytes. Mol. Biotechnol. 15, 133-142.
55. ROSENBERG, S.A., AEBERSOLD, P., CORNETTA, K., KASID, A., MORGAN, R., MOEN, R., KARSON, E., LOTZE, M., YANG, J., TOPALIAN, S., MERINO, M., CULVER, K., MILLER, A.D., BLAESE, R.M., and ANDERSON, W.F. (1990). Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323, 570-578.
56. SADELAIN, M., RIVIERE, I., and BRENTJENS, R. (2003). Targeting tumors with genetically enhanced T lymphocytes. Nat. Rev. Cancer 3, 35-45.
57. SALMON, P., KINDLER, V., DUCREY, O., CHAPUIS, B., ZUBLER, R.H., and TRONO, D. (2000). High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 96, 3392-3398.
58. SEDAR, R.A. (1994). Acquisition of lymphokine-producing phenotype by CD4+ T cells. J. Allergy Clin. Immunol. 94, 1195-1202.
59. + cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 88, 1043-1047.
60. TIBERGHIEN, P., REYNOLDS, C.W., KELLER, J., SPENCE, S., DESCHASEAUX, M., CERTOUX, J.-M., CONTASSOT, E., MURPHY, W.J., LYONS, R., CHIANG, Y., HERVE, P., LONGO, D.L., and RUSCETTI, F.W. (1994). Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation. Blood 84, 1333-1341.
61. TONG-STARKSEN, S.E., WELSH, T.M., and PETERLIN, B.M. (1990). Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals. J. Immunol. 145, 4348-4354.
62. TREISMAN, J., HWU, P., MINAMOTO, S., SHAFER, G.E., COWHERD, R., MORGAN, R.A., and ROSENBERG, S.A. (1995). Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood 85, 139-145.
63. TRONO, D. (2000). Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7, 20-23.
64. + T lymphocytes by MuLV-10A1 retrovirus pseudotype. Hum. Gene Ther. 11, 1005-1014.
65. UNUTMAZ, D., KEWALRAMANI, V.N., MARMON, S., LITTMAN, D.R. (1999). Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189, 1735-1746.
66. VERHOEYEN, E., DARDALHON, V., DUCREY-RUNDQUIST, O., TRONO, D., TAYLOR, N., and COSSET, F.L. (2003). IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101, 2167-2174.
67. VON SCHWEDLER, U., KORNBLUTH, R.S., and TRONO, D. (1994). The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 6992-6996.
68. WU, A.G., LIU, X., MAZUMDER, A., BELLANTI, J.A., and MEEHAN, K.R. (1999). Improvement of gene transduction efficiency in T lymphocytes using retroviral vectors. Hum. Gene Ther. 10, 977-982.
69. YANG, S., DELGADO, R., KING, S.R., WOFFENDIN, C., BARKER, C.S., YANG, Z.-Y., XU, L., NOLAN, G.P., and NABEL, G.J. (1999). Generation of retroviral vector for clinical studies using transient transfection. Hum. Gene Ther. 10, 123-132.
70. ZENNOU, V., PETIT, C., GUETARD, D., NERHBASS, U., MONTAGNIER, L., and CHARNEAU, P. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-185.
71. ZUFFEREY, R., NAGY, D., MANDEL, R.J., NALDINI, L., and TRONO, D. (1997). Multiple attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.
72. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.